Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00638898Phase 1Completed
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Adult Central Nervous System Germ Cell TumorAdult RhabdomyosarcomaChildhood Central Nervous System Germ Cell Tumor+27 more
PrincipalinvestigatorStart date: 2007-02-26
NCT00547196Not ApplicableCompleted
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
LeukemiaLymphomaMyelodysplastic Syndromes
PrincipalinvestigatorStart date: 2005-08-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Sarcoma, EwingLeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Alice P Chen, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

LymphomaMyelodysplastic SyndromesSolid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaSolid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

LymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Lorenzo Cohen, PhD

M.D. Anderson Cancer Center

Related
17 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Meir Wetzler, MD

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

LymphomaSolid Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00638898Phase 1PrincipalInvestigator

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Adult Central Nervous System Germ Cell TumorAdult RhabdomyosarcomaChildhood Central Nervous System Germ Cell Tumor+27 more
Completed
NCT00547196Not ApplicablePrincipalInvestigator

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

LeukemiaLymphomaMyelodysplastic Syndromes
Completed
NCT01129323Not ApplicablePrincipalInvestigator

Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia

Severe Aplastic Anemia
Withdrawn

All 3 trials loaded